Angiotech Pharmaceuticals (ANPI) Surges 40%+ for Second Straight Session
Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) is surging 40 percent higher today on heavier-than-normal volume.
There has been no news to explain the surge, but yesterday the stocks was up 49 percent so today is a continuation of that momentum.
The momentum seen in Angiotech Pharmaceuticals the past few sessions appears to be the same momentum seen in other sub-$1 biotech stocks for no apparent reason.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
There has been no news to explain the surge, but yesterday the stocks was up 49 percent so today is a continuation of that momentum.
The momentum seen in Angiotech Pharmaceuticals the past few sessions appears to be the same momentum seen in other sub-$1 biotech stocks for no apparent reason.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- Rossetta Genomics (ROSG) Sells 570K Shares at $11.50/Sh
- When Will Rosetta Genomics (ROSG) Crash From its 1346% Gain?
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
